CMAX Clinical Research has been a leader in delivering early phase clinical trials for over 30 years, making it one of the most respected clinical trial businesses in Australia.

Their modern custom-built facility is equipped with 78 inpatient beds and located opposite Royal Adelaide Hospital and Adelaide’s Bio-Med City, providing ready access to state-of-the-art facilities, equipment and world-class medical and pharmacology specialists.

As Australia’s longest-operating early phase unit, CMAX conducts successful world-leading research for local and international clients, specialising in a range of early-phase trials and first-time-in-human studies (FTIH).

Why work with us

•Complex Study Execution: Proven track record in executing complex studies with precision, with a huge focus on careful operational planning and risk mitigation from the start. Strong CRO partnerships and governance.

•The Originals: Pioneers in the field with 30+ years experience, with a reputation for being the unique, alternative choice to the larger, more corporate entities.

•Trust and Integrity: Known for honest, transparent, and integrity-driven practices, with executives available for escalations.

•Pharmacology Expertise: The scientist’s choice for Phase 1 site, renowned for pharmacology expertise led by the highly respected Professor Sepehr Shakib and team.

•Cost Transparency: Our dedication to minimising work order changes without altering the scope makes us a reliable partner, offering fewer change orders and enhanced budget predictability.